Written article 丨 Yu Hui

On April 26, the Ninth Session of the Standing Committee of the 14th National People's Congress adopted a report on the qualifications of individual representatives on the qualifications of the representative of the 14th National People's Congress Standing Committee.

The

Report shows that the 14th National People's Congress of Hebei Province, representative of the National People's Congress, Han Shuwang, former chairman and party secretary of Aerospace Investment Holdings Co., Ltd., was suspected of serious disciplinary violations. 2024On March 28, the eighth meeting of the Standing Committee of the 14th National People's Congress of Hebei Province decided to dismiss the position of the 14th National People's Congress of Han Shwang.

According to the relevant provisions of the National People's Congress of the People's Republic of China and the representative law of the People's Congress at all levels, Han Shwang's representative qualifications are terminated.

This is the first time that Han Shwang was suspected of serious disciplinary violations.

Han Shwang was the executive deputy general manager of Aerospace Investment Holding Co., Ltd., chairman of the Aerospace Guoxuan (Tangshan) Lithium Battery Co., Ltd., director, general manager, and deputy secretary of the party committee of Aerospace Investment Holdings Co., Ltd.

In 2021, Han Shwang served as chairman and party secretary of Aerospace Investment Holding Co., Ltd.

According to Surging News, Aerospace Investment Holdings Co., Ltd. was established in December 2006 and was officially operated in March 2008 to fulfill the functions of industrial incubation, resource integration, strategic mergers and acquisitions, investment and financing given by China Aerospace Technology Group Co., Ltd.

In addition to Han Shwang, Xu Nuojin, Gu Zhengju, and Yang Xiaoming have also been removed from the positions of representatives of the National People's Congress.

  • selected by Henan Province selectedThe representative of the Fourteenth National People's Congress, Xu Nuojin, former deputy chairman of the Finance and Economic Committee of the Henan Provincial People's Congress, was suspected of serious disciplinary violations.The eighth meeting of the Standing Committee of the People's Congress decided to remove the position of the 14th National People's Congress of Xu Nuojin.

  • Representative of the 14th National People's Congress selected by Sichuan Province, The former Secretary of the Nanchong Municipal Party Committee of Sichuan ProvinceGu Zhengju was suspected of serious disciplinary violations. On April 3, 2024, the 11th meeting of the Standing Committee of the 14th National People's Congress of Sichuan Province decided to dismiss Gu Zhengju's 14th National People's Congress.Position.

  • representative of the 14th National People's Congress selected by the Tibet Autonomous Region, member of the Fourteenth National People's Congress National Committee, Yang Xiaoming, former chief engineer and chief scientist of China Pharmaceutical Group Co., Ltd., was suspected of serious disciplinary violations. On March 29, 2024, the Ninth Meeting of the Standing Committee of the Twelfth People's Congress of the Tibet Autonomous Region decided to dismiss Yang Xiaoming'sThe 14th National People's Congress.

According to the relevant provisions of the National People's Congress of the People's Republic of China and the representative law of the People's Congress at all levels, Xu Nuojin, Gu Zhengju, and Yang Xiaoming's representative qualifications were terminated.

This is also the first time that Yang Xiaoming, the former chief engineer and chief scientist of China Pharmaceutical Group Co., Ltd., was suspected of serious disciplinary violations.

China Pharmaceutical Group Co., Ltd. (referred to as "National Medicine Group") is a central enterprise that is directly managed by the State -owned Assets Supervision and Administration Commission of the State Council.

Yang Xiaoming, born in February 1962, is born in Zhouqu County, Gansu Province, an expert in biological products.In 1980, he was admitted to the Department of Clinical Medicine of Lanzhou University School of Medicine and was assigned to the Lanzhou Biological Products Research Institute after graduation.

In 1997, Yang Xiaoming went to the National Institute of Health (NIH) to engage in the research of molecular microbes and vaccine.

In 2002, Yang Xiaoming returned to China as executive deputy director of the Wuhan Institute of Biological Products.Since 2010, Yang Xiaoming has worked in China Biotechnology Co., Ltd., which is affiliated to China Medicine Group.

He was the director of the National Joint Vaccine Engineering Technology Research Center, chief scientist of the National "863" plan vaccine project, and chairman of China Biology.

It is reported that Yang Xiaoming focused on the basic research of infectious disease vaccine application, the creation of the engineering technology system, and the creation of major products for nearly 40 years, and has long been committed to the innovation of infectious disease vaccine.

Information ｜ Xinhua News Agency People's Daily CCTV Benliu News Surging News and other